v3 Template
P

Promise Bio

Biotechnology/Healthcare ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$8.3M
Funding Rounds
1
Last Funding
2024-12-16

About Promise Bio

PromiseBio is pioneering precision medicine for autoimmune diseases by deciphering the 'dark matter' of proteomics and revealing biologically relevant insights. Their mission is to enable precision medicine and boost drug development through advanced epiproteomic analysis.

Products & Services

Cloud-based AI Platform:A platform that performs unbiased, broad-range epiproteomic analyses on standard mass-spectrometry data to uncover hidden insights.
Epiproteomic Analysis:Focuses on studying post-translational modifications (PTMs) of proteins to understand disease mechanisms, predict responses, and stratify patients for autoimmune diseases.

Specialties

Precision Medicine Epiproteomics Autoimmune Diseases AI-driven Proteomics Biomarker Discovery Patient Stratification

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 8300000
MR: -
FA: 8.3 million
FAN: 8300000 		D: 2024-12-16
FD: 2024-12-16 		5 investors
Seed Latest
2024-12-16
$8.3M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Ronel Veksler

Co-founder & CEO

LinkedIn (Pro only)
A

Assaf Kacen

Co-founder & CTO

LinkedIn (Pro only)
Y

Yifat Merbl

Scientific co-founder

LinkedIn (Pro only)

Recent News

Promise Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~30 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro